|
1
|
Naeem A, Tun AM and Guevara E: Molecular
genetics and the role of molecularly targeted agents in metastatic
colorectal carcinoma. J Gastrointest Cancer. 51:387–400. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weinberg BA, Marshall JL and Salem ME: The
growing challenge of young adults with colorectal cancer. Oncology
(Williston Park). 31:381–389. 2017.PubMed/NCBI
|
|
3
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ravegnini G and Angelini S: Toward
precision medicine: How far is the goal? Int J Mol Sci. 17:2452016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson TM: Perspective on precision
medicine in oncology. Pharmacotherapy. 37:988–989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei Q: Personalized medicine at a prime
time for cancer medicine-introducing cancer medicine. Cancer Med.
1:12012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mork ME, You YN, Ying J, Bannon SA, Lynch
PM, Rodriguez-Bigas MA and Vilar E: High prevalence of hereditary
cancer syndromes in adolescents and young adults with colorectal
cancer. J Clin Oncol. 33:3544–3549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan SA, Morris M, Idrees K, Gimbel MI,
Rosenberg S, Zeng Z, Li F, Gan G, Shia J, LaQuaglia MP and Paty PB:
Colorectal cancer in the very young: A comparative study of tumor
markers, pathology and survival in early onset and adult onset
patients. J Pediatr Surg. 51:1812–1817. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Magnani G, Furlan D, Sahnane N, Reggiani
Bonetti L, Domati F and Pedroni M: Molecular features and
methylation status in early onset (≤40 years) colorectal cancer: A
population based, case-control study. Gastroenterol Res Pract.
2015:1321902015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pearlman R, Frankel WL, Swanson B, Zhao W,
Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, et
al: Prevalence and spectrum of germline cancer susceptibility gene
mutations among patients with early-onset colorectal cancer. JAMA
Oncol. 3:464–471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41((Database Issue)):
D991–D995. 2013.PubMed/NCBI
|
|
12
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang L, Wang J, Sun X, Cao Y, Ning S,
Zhang H, Chen L, Li R, Tian Q, Wang L, et al: Identifying a
polymorphic ‘switch’ that influences miRNAs' regulation of a
myasthenia gravis risk pathway. PLoS One. 9:e1048272014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Zheng R, Zhang H and He T: Pathway
crosstalk analysis of microarray gene expression profile in human
hepatocellular carcinoma. Pathol oncol Res. 21:563–569. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marjon PL, Bobrovnikova-Marjon EV and
Abcouwer SF: Expression of the pro-angiogenic factors vascular
endothelial growth factor and interleukin-8/CXCL8 by human breast
carcinomas is responsive to nutrient deprivation and endoplasmic
reticulum stress. Mol Cancer. 3:42004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsushima K, Baldwin ET and Mukaida N:
Interleukin-8 and MCAF: Novel leukocyte recruitment and activating
cytokines. Chem Immunol. 51:236–265. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T,
Chen Y, Han X and Wu K: The CXCL8-CXCR1/2 pathways in cancer.
Cytokine Growth Factor Rev. 31:61–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masuya D, Huang C, Liu D, Kameyama K,
Hayashi E, Yamauchi A, Kobayashi S, Haba R and Yokomise H: The
intratumoral expression of vascular endothelial growth factor and
interleukin-8 associated with angiogenesis in nonsmall cell lung
carcinoma patients. Cancer. 92:2628–2638. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamamoto Y, Kuroda K, Sera T, Sugimoto A,
Kushiyama S, Nishimura S, Togano S, Okuno T, Yoshii M, Tamura T, et
al: The clinicopathological significance of the CXCR2 ligands,
CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in gastric
cancer. Anticancer Res. 39:6645–6652. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liubomirski Y, Lerrer S, Meshel T, Morein
D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich
M and Ben-Baruch A: Notch-mediated tumor-stroma-inflammation
networks promote invasive properties and CXCL8 expression in
triple-negative breast cancer. Front Immunol. 10:8042019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai
X, Xia C and Li Y: CXCL8 induces epithelial-mesenchymal transition
in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Oncol Rep. 37:2095–2100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doll D, Keller L, Maak M, Boulesteix AL,
Siewert JR, Holzmann B and Janssen KP: Differential expression of
the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and
their impact on metastatic disease and survival. Int J Colorectal
Dis. 25:573–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao QQ, Jiang C, Gao Q, Zhang YY, Wang G,
Chen XP, Wu SB and Tang J: Gene expression and methylation profiles
identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis
of colon adenocarcinoma. J Cell Physiol. 235:4902–4912. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Das ST, Rajagopalan L, Guerrero-Plata A,
Sai J, Richmond A, Garofalo RP and Rajarathnam K: Monomeric and
dimeric CXCL8 are both essential for in vivo neutrophil
recruitment. PLoS One. 5:e117542010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Herbert SP and Stainier DY: Molecular
control of endothelial cell behaviour during blood vessel
morphogenesis. Nat Rev Mol Cell Biol. 12:551–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang SD, McCrudden CM and Kwok HF:
Prognostic significance of combining VEGFA, FLT1 and KDR mRNA
expression in lung cancer. Oncol Lett. 10:1893–1901. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu J, Wang YH, Yoon C, Huang XY, Xu Y, Xie
JW, Wang JB, Lin JX, Chen QY, Cao LL, et al: Circular RNA
circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to
facilitate gastric cancer invasion and metastasis. Cancer Lett.
471:38–48. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Korobeinikova E, Ugenskiene R, Insodaite
R, Rudzianskas V, Jaselske E, Poskiene L and Juozaityte E:
Association of angiogenesis and inflammation-related gene
functional polymorphisms with early-stage breast cancer prognosis.
Oncol Lett. 19:3687–3700. 2020.PubMed/NCBI
|
|
34
|
Zhou P, Xiong T, Chen J, Li F, Qi T and
Yuan J: Clinical significance of melanoma cell adhesion molecule
CD146 and VEGFA expression in epithelial ovarian cancer. Oncol
Lett. 17:2418–2424. 2019.PubMed/NCBI
|
|
35
|
Wang R, Ma Y, Zhan S, Zhang G, Cao L,
Zhang X, Shi T and Chen W: B7-H3 promotes colorectal cancer
angiogenesis through activating the NF-κB pathway to induce VEGFA
expression. Cell Death Dis. 11:552020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ferrara N and Adamis AP: Ten years of
anti-vascular endothelial growth factor therapy. Nat Rev Drug
Discov. 15:385–403. 2016. View Article : Google Scholar : PubMed/NCBI
|
